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Abstract
Objective—Hallux valgus (HV) affects ~36% of Caucasian adults. Although considered highly 
heritable, the underlying genetic determinants are unclear. We conducted the first genome-wide 
association study (GWAS) aimed to identify genetic variants associated with HV.
Methods—HV was assessed in 3 Caucasian cohorts (n=2,263, n=915, and n=1,231 participants, 
respectively). In each cohort, a GWAS was conducted using 2.5M imputed single nucleotide 
polymorphisms (SNPs). Mixed-effect regression with the additive genetic model adjusted for age, 
sex, weight and within-family correlations was used for both sex-specific and combined analyses. 
To combine GWAS results across cohorts, fixed-effect inverse-variance meta-analyses were used. 
Following meta-analyses, top-associated findings were also examined in an African American 
cohort (n=327).
Results—The proportion of HV variance explained by genome-wide genotyped SNPs was 50% 
in men and 48% in women. A higher proportion of genetic determinants of HV was sex-specific. 
The most significantly associated SNP in men was rs9675316 located on chr17q23-a24 near the 
AXIN2 gene (p=5.46×10−7); the most significantly associated SNP in women was rs7996797 
located on chr13q14.1-q14.2 near the ESD gene (p=7.21×10−7). Genome-wide significant SNP-
by-sex interaction was found for SNP rs1563374 located on chr11p15.1 near the MRGPRX3 gene 
(interaction p-value =4.1×10−9). The association signals diminished when combining men and 
women.
Conclusion—Findings suggest that the potential pathophysiological mechanisms of HV are 
complex and strongly underlined by sex-specific interactions. The identified genetic variants imply 
contribution of biological pathways observed in osteoarthritis as well as new pathways, 
influencing skeletal development and inflammation.
Keywords
hallux valgus; GWAS; genetic variants; candidate genes
INTRODUCTION
Foot disorders affect 20-60% of community-dwelling older adults[1-3] and are associated 
with disability[1] and falls[1, 4-6]. Hallux valgus (HV), a condition in which the great toe 
deviates laterally at the 1st metatarso-phalangeal joint, is a common foot disorder in adults 
that is more prevalent among older than younger individuals[7], women than men[8-10], and 
African Americans than Caucasians[3, 10]. Body weight and poor shoe wear have reported 
to be risk factors for HV[8, 11, 12], and genetic predisposition may also contribute to this 
condition. Pedigree studies have found that 63-90% of individuals with HV report a family 
history of the condition[13-15]. More recently, HV was found to be highly heritable in the 
Framingham Heart Study[16] (involving 1,370 European descent Caucasian participants 
from 429 families) and the Korean Healthy Twin Study (involving 1,265 East Asian 
participants and 206 twin pairs)[17]. Although these studies suggest that HV may be 
hereditary, no candidate gene association study or genome-wide association study (GWAS) 
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has been conducted to examine the genetic predisposition of HV. Identifying genetic factors 
associated with HV may further our understanding of the biological mechanisms underlying 
this condition and may help clinicians and researchers target high-risk individuals in need of 
early intervention approaches to prevent or slow functional decline[18].
The purpose of the present study was to conduct a GWAS meta-analysis of HV in older 
Caucasian adults from the Framingham Heart Study (FHS), the Johnston County 
Osteoarthritis Project (JoCo OA), and the Genetics of Generalized Osteoarthritis (GOGO) 
Study. Due to known differences in the prevalence of HV by sex and by race, sex-specific 
analyses of FHS, JoCo OA, and GOGO were conducted and the generalizability of the 
genetic findings was examined in the African American sub-sample of the JoCo OA.
MATERIALS and METHODS
Study Populations
This GWAS meta-analysis was conducted using data from three cohort studies and was 
approved by the Institutional Review Boards for Human Subjects Research at Boston 
University and the Hebrew Rehabilitation Center for the Framingham Foot Study and by the 
University of North Carolina and the Centers for Disease Control and Prevention for JoCo 
OA. Institutional Review Boards of Duke University Medical Center, University of North 
Carolina, Rush University, the University of Maryland, Case Western Reserve University, 
the University of Nottingham, and Sheffield University approved the GOGO study.
Framingham Heart Study (FHS)—The FHS comprised of members from the 
Framingham Study Original Cohort[19], the Framingham Offspring Cohort[20]. The 
Framingham Study Original Cohort was formed in 1948 from a two-thirds sample of the 
town of Framingham, MA in order to study risk factors for heart disease. The Framingham 
Offspring cohort, formed in 1972, consists of adult offspring who had a parent in the 
Original Cohort, and the spouses of the offspring. The cohorts have been followed every 2 to 
4 years since cohort inception to study familial risk factors for cardiovascular, neurological, 
metabolic and musculoskeletal diseases. The Framingham Foot Study is an ancillary study 
of the FHS with the goal to examine the contribution of foot disorders to functional 
limitation and disability. Members of the FHS who participated at the Exam during 
2002-2006 were examined for the Framingham Foot Study (n=2,263).
Johnston County OA Project (JoCo OA)—JoCo OA began in 1990 as a community-
based prospective cohort of Caucasians and African-American men and women with and 
without osteoarthritis (OA)[21]. JoCo OA was designed to estimate the incidence and 
progression of knee and hip osteoarthritis (OA) among Caucasians and African Americans, 
and the study has expanded to study the hand, lumbar spine, ankles, and feet during 
successive follow-up visits (occurring approximately every 5 years). The sampling methods 
and study protocol have been previously reported[22]. At baseline, 3,187 Caucasian and 
African American adults aged 45 years or older (35% men; 32% African American; mean 
age 61 ±10 years) were recruited from 6 townships in Johnston County, North Carolina and 
completed a clinical examination visit during 1991-97. An additional 1,019 Johnston County 
residents 45+ years old were enrolled and attended a clinic visit during 2003-2004. The 
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genotyped sample consists of those participants from baseline who returned for the first 
follow-up from 1999-2003, and the enrichment cohort of new participants in 2003-04. A 
total of 915 Caucasians and 327 African Americans with both HV phenotype and GWAS 
genotypes were in the final analyses.
Genetics of Generalized Osteoarthritis (GOGO) Study—GOGO is an investigator-
initiated collaboration involving seven clinical academic sites in the United States and 
United Kingdom, whose data collection was sponsored by GlaxoSmithKline[23]. Family 
ascertainment occurred between 1999 and 2002. A qualifying family required self-reported 
Caucasian ethnicity and at least two affected siblings with clinical hand OA with 
radiographic evidence involving at least 3 hand joints distributed bilaterally and at least one 
distal inter-phalangeal joint, with two of the three involved joints within a single joint group. 
Clinical examination data of the hands, knees, hips, and feet, including HV, were collected. 
Additional siblings and living parents from qualifying families, both affected and unaffected, 
were invited to participate. A total of 2,728 participants from 1,145 families met the pre-
specified radiographic criteria for affected status. The mean age of all the samples was 66 
years and women constituted 80.4% of the sample. Among them, 1,231 participants had 
information on both HV phenotype and GWAS genotypes for the analyses.
Assessment of Hallux Valgus
HV was assessed in the FHS by podiatrist-trained clinical examiners who conducted a visual 
and physical examination of a participant's feet during weight-bearing[24]. In JoCo OA and 
GOGO studies, participants stood on a laminated foot mat with an illustration of two lines 
drawn at a 15 degree angle. In all three cohorts, HV was considered present if the examiner 
determined that the lateral deviation of the hallux with respect to the first metatarsal was 15° 
or more[25]. HV was considered absent if this criterion was not met.
Other Covariates
Possible confounders included age, sex, and body mass index (BMI). Age at exam was 
recorded. Weight in pounds was measured using a standardized balance beam scale and 
recorded to the nearest ½ pound. Height (without shoes) was measured in inches using a 
calibrated stadiometer and recorded to the nearest ¼ inch (to ½ inch in JoCo OA). BMI was 
calculated as weight in kilograms divided by height in meters squared.
GWAS Genotyping and Quality Controls
Details of genotyping and quality controls in each study are described in Supplementary 
Table 1. In brief, for the FHS, genotyping was conducted by the FHS SHARe (SNP Health 
Association Resource) Project, for which 549,827 SNPs (Affymetrix 500K mapping array 
plus Affymetrix 50K supplemental array) were genotyped in over 9,274 FHS subjects from 
over 900 families[26]. SNPs were excluded due to low call rate (< 95%), significant 
deviation from Hardy-Weinberg equilibrium (p < 10−6 by HWE test), or unknown genomic 
annotation [26]. A total of 2,593 subjects from the JoCo OA cohort were genotyped by 
Algynomics, Inc. using the Illumina 1M-Duo platform, which interrogates 1,199,187 SNPs. 
The SNPs chosen for this array were selected to tag 93% of common SNPs in the Caucasian 
European (CEU) population at r2 ≥ 0.8.[27] For the GOGO Study, a total of 610,000 SNPs 
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(Illumina HumanHap 610 Quad v1 array plus 60,000 custom tag SNPs selected from 
HapMap CEU panel) were genotyped. PEDCHECK[28] and RELPAIR[29] programs were 
used to check for errors in Mendelian inheritance and inconsistencies within pedigrees at all 
marker loci.
Population Substructure in each participating cohort
Principal component analysis (PCA) was used to estimate genetic ancestry separately in 
each of the FHS, JoCo OA and GoGo studies [30]. To account for potential population 
substructure in the SNP-HV association tests, we adjusted PCs that associated with traits at 
nominal p-values less than 0.05 (estimated separately in each study), along with other 
covariates in the regression models. In addition, in the JoCo OA, an identity-by-state matrix 
was estimated to verify the self-reported race (Caucasian and African Americans). PCA was 
used to estimate population sub-structure within Caucasian samples and within African 
American samples, separately.
Imputation for non-genotyped SNPs
For all genotyped individuals, the International HapMap II CEU reference panel was used to 
impute 2,543,887 SNPs by MACH [31]. To account for the uncertainty of imputation, the 
additive dosage of the allele from 0 to 2 was used to perform association tests. The ratio of 
the empirically observed dosage variance (from the imputed genotypes) to the expected 
(under binomial distribution) dosage variance (computed from the estimated minor allele 
frequency) was estimated for every SNP as a quality score for imputation. SNPs with the 
variance ratio < 0.3 were excluded from association analysis. For the African Americans in 
JoCo OA, IMPUTE v2 [32] with a mixed panel of international HapMap II CEU and YRI 
references were used to impute un-genotyped SNPs.
Statistical Analyses
Single-SNP GWAS Analysis in Each Study
Gender-specific GWAS analyses were performed for each study. A SNP in additive genetic 
effect model was the independent variable. The dependent variable was HV dichotomous 
status (1 as subjects having HV; and 0 as subjects without −HV). HV was analyzed as a 
dichotomous phenotype. Other covariates included age, sex, cohort-specific sub-studies/
study sites (For FHS and GOGO studies only), BMI and PCs (ancestral genetic background 
to adjust for population substructure). For FHS and GOGO studies, to account for the 
within family correlations of the HV phenotype, the generalized estimating equations (GEE) 
model with Kinship matrix implemented in R-GEEpack [33] was used.. For JoCo OA 
(Caucasian American only), a logistic regression was applied. To estimate how well the 
distribution of the null hypothesis was calibrated, for each study, we estimated the genomic 
inflation factor (ţGC) based on the median chi-squared test of all study participants.[34] 
Quantile-Quantile (Q-Q) plots were also created to evaluate if there was any systematic bias, 
such as genotyping errors or population stratification. Gender-combined GWAS analysis was 
also performed to identify SNPs that were associated with both men and women.
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Meta-Analyses—To combine GWAS results from three Caucasian samples, we performed 
the fixed-effect inverse-variance meta-analyses implemented in METAL package (http://
www.sph.umich.edu/csg/abecasis/Metal/). All association results were expressed relative to 
the forward strand of the reference genome based on the international HapMap project II 
reference panel. For each study, we excluded ~20% of the imputed SNPs with either 
imputation quality score “ratio” < 0.3 or minor allele frequency (MAF) < 0.005 . We also 
applied genomic inflation factor (ţGC) correction to the standard error of the beta 
coefficients of the SNP-HV associations in each study. After meta-analyses, we further 
excluded SNPs with association results from only one study, heterogeneity tests p-values 
less than 5×10−6 or heterogeneity I2 > 50. We estimated the genomic inflation factor (ţGC) 
and plotted Quantile-Quantile plots. Meta-analysis p-value < 5×10−8 was considered as the 
genome-wide significance threshold.
SNP-by-Sex Interactions—To examine the SNP-by-sex interactions for those top 
associated SNPs found from male or female meta-analysis only, we estimated the SNP-by-
sex interaction effects by  with its corresponding standard error 
, where  and  are sex-specific from meta-
analyses. P-values are estimated by Cochran's Q test [35]. This Cochran's Q heterogeneity 
test in meta-analysis is equivalent to the traditional multivariate interactions model to test the 
SNP-by-sex interaction term in a general linear regression model.
The Generalizability of the Top Associated SNPs in JoCo OA African American samples
Due to small sample size, we did not perform GWAS on JoCo OA African American 
samples; instead, to reduce the multiple testing penalties, SNPs with meta-analysis p-values 
< 10−5 from the Caucasian populations were selected to test for associations with HV in the 
JoCo OA African American samples. In addition, to take into account the potential 
difference in the LD structure between Caucasians and African Americans, we also selected 
additional SNPs in high LD (r2 ≥ 0.8) with the targeted SNPs (SNPs selected from 
Caucasian samples) in JoCo OA African American samples and tested their associations 
with HV. A GEE-based logistic regression model with robust variance was applied. Other 
covariates included age, sex, BMI and PCs (ancestral genetic background to adjust for 
population substructure). False discovery rate (FDR),[36] q-value < 0.05 was used to 
estimate multiple testing corrected p-values.
RESULTS
Prevalence of Hallux Valgus (HV) in study samples
The prevalence of HV, stratified by sex in each study, is shown in Table 1. A total of 4,409 
Caucasians (2,827 women and 1,582 men) from FHS, JoCo OA, and GOGO studies were 
included in the GWAS meta-analysis. A sub-sample of 327 African Americans from JoCo 
OA was analyzed. Key features of the study populations are summarized in Table 1. HV was 
less prevalent in FHS participants than in JoCo OA and GOGO Caucasian samples. The sex-
specific prevalence of HV was quite different across the three studies. Among women, HV 
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was present in 41%, 65% and 44% of FHS, JoCo OA and GOGO, respectively, and among 
men, HV was present in 19%, 56% and 32%, respectively. The prevalence of HV in both 
FHS men and women was comparable to the pooled prevalence of older populations (> 65 
years old) reported in a recent systematic review of 78 publications (36%)[7].
Sex-specific GWAS meta-analysis
We first estimated the proportion of HV variance that could be explained by the genotyped 
SNPs in the FHS. The proportion of HV variance explained by genome-wide genotyped 
SNPs was 50% in men and 48% in women (30% when men and women combined). We 
found 33% of those genetic determinants were sex-specific, suggesting that a higher 
proportion of genetic determinants of HV were sex-specific and affected only either men or 
women. Therefore, we focused primarily on sex-specific GWAS meta-analysis. Q-Q plots of 
gender-specific GWAS results are shown in Supplementary Figure 1. No SNP reached the 
genome-wide significance level at 5×10−8 in either the single cohort GWAS or in the meta-
analysis. However, we did observe a set of potentially suggestive SNPs with p-values less 
than 5×10−6 in male-specific and female-specific analyses. The false discovery rate of these 
suggestive associations ranged from 0.08 to 0.15.
In men, the most significantly associated SNP was rs9675316 located on chr17q23-q24 near 
the AXIN2 gene (p-value=5.46×10−7). Regional plots are shown in Supplementary Figure 
2. SNP rs9675316 was less common in the study populations with a MAF = 1%. Men 
carrying one copy of the risk allele (G) resulted in a 3-times increased risk of HV comparing 
to men without “G” alleles. We did not find an association between rs9675316 and risk of 
HV in women (p=0.1). A significant SNP-by-sex interaction (p=6.8×10−5) of rs9675316 
indicated a male-specific genetic effect of rs9675316. The remaining genome-wide 
suggestive association loci (meta-analysis p-values < 5×10−6) are listed in Table 2. All of 
the suggestive loci showed male-specific effects by testing SNP-by-sex interactions.
Similarly in women, we did not find genome-wide significant (p < 5×10−8) associations with 
HV. The most significantly associated SNP was rs7996797 (average MAF=39% in study 
samples) located on chr13q14.1-q14.2 near the ESD gene with p-value=7.21×10−7. Regional 
plots are shown in Supplementary Figure 3. Women carrying one copy of the risk allele 
(A) had a 1.4-times increased risk of HV compared to women without “A” alleles. SNP 
rs7996797 was not associated with HV in men (p=0.7). A strong SNP-by-sex interaction 
(p=3.3×10−3) of rs7996797 indicated a female-specific genetic effect of rs7996797. The 
remaining genome-wide suggestive association loci are listed in Table 2. None of the 
suggestive loci showed nominal association in men (p > 0.05).
Sex-by-SNP interactions
To further explore the potential sexual dimorphism in HV, we performed an autosomal 
genome-wide meta-analysis of sex-by-SNP interactions to identify genetic variants with 
different effects by sex. SNP-by-sex interaction with genome-wide significance was found 
for SNP rs1563374 located on chr11p15.1 near the MRGPRX3 gene (interaction p-value 
=4.1×10−9). SNP rs1563374 was less common in our study populations, ~2% in both men 
and women in the meta-analysis of three studies together. Although the effect size (beta-
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coefficient of association between rs1563374 and the risk of HV) was quite similar, the 
effect direction of SNP rs1563374 was opposite between men and women (Table 3). Men 
carrying the minor allele A had a higher risk of HV (beta coefficient=1.73, meta-analysis p-
value=2.6×10−5), but women carrying the same minor allele A had a protective effect (beta 
coefficient=-1.24, meta-analysis p-value=2.3×10−5). Due to the opposite direction of the 
effects, the sex-combined association between rs1563374 and HV was not significant (Men 
+ Women p-value=0.31). The genome-wide suggestive interaction loci (p-values < 5×10−6) 
are listed in Table 3. All of the SNPs in the listed loci had similar MAFs, but opposite 
effects between men and women. We also performed a sex-combined GWAS meta-analysis 
without sex-by-SNP interaction terms to identify common genetic determinants of HV in 
both men and women. We did not find genome-wide significant associations. Overall, the 
association signals diminished compared to the association signals estimated from sex-
specific analyses (Supplementary Table 2).
African Americans
None of the suggestive loci was associated with HV in the small subset of JoCo African 
Americans (Supplementary tables 3 to 6).
DISCUSSION
HV is one of the most common foot disorders in older Caucasian and African Americans [3, 
10] and has been confirmed to be heritable in our recent publication[16]. In this first ever 
GWAS meta-analysis of HV, we report a set of potentially suggestive SNPs with p-values 
less than 5×10−6 in male-specific and female-specific analyses. We identified SNPs with 
genome-wide significant interactions with sex. A strong sex difference in the prevalence of 
HV has been reported in epidemiological studies[7, 37]. One potential explanation for such 
sex-specific predisposition to HV risk is the possibility that the observed differences 
between men and women are driven by genetic effects determining skeletal structure (such 
as an increased intermetatarsal angle, longer first metatarsal and round first metatarsal 
head[38]). Based on our sex-specific heritability estimation, we also found 33% of those 
genetic determinants were sex-specific. Several recent studies suggest that sex-specific 
genetic architecture influences many human diseases and phenotypes, such as blood 
pressure, hypertension, schizophrenia, bone mineral density, osteoporotic fractures and 
reproductive relevant diseases[39]. Some of the underlying mechanisms might be attributed 
to differential gene regulation in males and females, particularly in sex hormonal responsive 
genes; the potential contribution of sex chromosomes; as well as the interaction between 
genetic determinants and sex-specific environmental risk factors. Several strong gene-by-sex 
interactions were observed. However, the identified genes are neither those obviously 
involved in sex hormones, nor well-studied regarding their differential regulation in men and 
women. We identified one genome-wide significantly associated sex-interacted SNP 
rs1563374 located in the 5’  flanking of the MRGPRX3 gene. The MRGPRX3 gene encodes 
a member of the mas-related/sensory neuron specific subfamily of G protein-coupled 
receptors. The encoded protein may be involved in sensory neuron regulation and in the 
modulation of pain and/or itch[40]. In men, minor alleles of rs1563374 were associated with 
a higher HV risk. A recent study[41] has shown increased methylation with age in the 
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MRGPRX3 gene in males only; and, in addition, that study also showed differential 
methylation in the MRGPRX3 gene in male infants associated with peri-conceptional 
environment, but not in female infants, suggesting a potential sexual dimorphism of 
MRGPRX3 gene regulation. The underlying function of these identified variants/genes will 
need to be further elucidated. Due to the limitation of the quality of the X chromosomal 
imputation, we did not perform gene-by-sex interactions in the sex chromosomes, which did 
not allow us to examine the contribution of sex chromosomes.
In men, the most significant finding was the SNP rs9675316 which is located near the gene 
AXIN2. The AXIN2 gene encodes the Axin-related protein, which plays an important role 
in the regulation of the stability of beta-catenin in the Wnt signaling pathway[42]. AXIN2 
variants have been reported to be associated with risks of oral clefts[43]. Another top 
associated SNP, rs10224956, is located near gene BBS9. BBS9 is involved in parathyroid 
hormone action in bone and is down-regulated by parathyroid hormone in osteoblasts. The 
SNP-by-sex interaction analysis on rs10224956 also confirmed its male-specific genetic 
effect. A recent GWAS identified a susceptibility locus for non-syndromic sagittal 
craniosynostosis within BBS9, which indicates that BBS9 may play an important role in 
skeletal development[44]. The association between BBS9 and HV is consistent with the 
concept that HV may result from a long-term complex process involving interaction between 
bones and soft tissues of the foot. In addition, the association between FAT4 and HV 
identified in our study might be additional evidence to support its regulatory function in 
bone formation and the importance of bone formation in HV, since FAT4 gene is critical 
regulators of osteoblast development in Fat4 mouse mutant (unpublished data: Fat-Hippo 
regulation of osteoblast differentiation).
In women, the most significant finding was the SNP rs7996797 which is located in gene 
ESD. The ESD gene encodes a serine hydrolase that is involved in the recycling of sialic 
acids[45]. Interestingly, increased serum sialic acid level is associated with decreased 
antioxidant levels in people with primary OA [46]. The association between HV and the 
ESD gene suggests that HV, which is associated with OA of the first metatarsophalangeal 
joint [47, 48], might share similar mechanisms with other OA phenotypes. ANXA1 
(rs4744678), also known as Annexin I, belongs to a family of Ca2+ dependent phospholipid 
binding proteins and is required for biosynthesis of potent mediators of inflammation, 
prostaglandins and leukotrienes, ANXA1 may have potential anti-inflammatory activity. 
Inflammation is well-known to be associated with OA [49], and this association with HV in 
women suggests that inflammation may be important in HV as well.
Similar to many GWAS analyses, with limited sex-specific sample size, lack of statistical 
power may be a potential explanation of no genome-wide significant findings (p < 5×10−8). 
To achieve power ≥ 70% for detecting associations for common SNPs (MAF ≥ 5%) under 
additive genetic effect model with effect size 1.1 to 2.0 odds ratios (ORs), we will need to 
have at least 8,240 samples in each sex. To our knowledge, we have gathered all of the 
available Caucasian studies with HV phenotypes and genome-wide genotyping in the world 
thus far. Our findings suggest that HV is heterogeneous, with multiple genetic risk factors 
involved in different biologic pathways and with potential interactions with sex. It is likely 
that there are multiple causal SNPs, each of which has a small effect; therefore, more 
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cohorts to be genotyped or phenotyped are needed to have adequate power to detect 
moderate SNP effects. Although, we estimated > 80% genomic coverage (Linkage 
disequilibrium, LD, r2>0.8) of the HapMap Phase I+II common SNPs with MAF ≥ 0.05 for 
the Caucasian population.[50]; better/more dense genotyping coverage for both uncommon 
and common variants (such as imputation using the recent available 1000Genome Project 
Phase III reference panel with 2,050 whole genome sequences) may also improve our effort 
to discovery genetic variants associated with HV. It is reasonable to consider the hidden 
heritability in uncommon and rare variants as well. However, based on our sample size and 
effect size (ORs=1.1 to 2.0) we observed so far, we do not have statistical power (power < 
30%) to detect association signals for uncommon variants (MAF < 5%).
The gender-specific loci that we discovered are considered robust due to the same effect 
direction and similar effect magnitude observed across three Caucasian studies. However, 
we failed to observe significant associations in the JoCo African Americans for these 
suggestive loci. It may be due to (1) difference in allele frequencies and LD among 
Caucasians and African Americans as shown in Supplementary Tables 3 to 6; (2) very 
small sample size (327 African Americans) with limited statistical power; (3) heterogeneity 
in non-genetic exposure (gene-by-environment interactions); and/or (4) polygenetic etiology.
Study heterogeneity across three participating cohorts may also explain our lack of genome-
wide association findings. We found several strong associated SNPs in each cohort 
(Supplementary Tables 3 to 6), but only one SNP (rs9626245 in supplementary Table 4), 
located in an intron of the PRR5-ARHGAP8 read-through mRNA, was replicated in another 
cohort (JoCo OA African American, p=0.009) and this did not pass our FDR q-value < 0.05 
threshold. This SNP is adjacent to the ARHGP8 gene for the Rho GTPase activating protein 
8 that encodes a member of the RHOGAP family of proteins that participate in signaling 
pathways that regulate cell processes involved in cytoskeletal changes. The remaining 
associations in individual cohorts failed to replicate in the other two cohorts. Some of these 
associations from each cohort may be false-positives, suggesting the possibility of study 
heterogeneity across three participating cohorts. The heterogeneity can be due to difference 
in HV assessment, ancestral genetic background and environmental exposures. To identify 
the source of study heterogeneity, we compared ancestral genetic backgrounds across the 
three studies by PCA of genome-wide genotypes. We did not find any deviation from the 
ancestral genetic background of the CEU (in HapMap Project) samples. In addition, the 
allele frequencies were similar among three studies. Therefore, we ruled out major 
differences in ancestral genetic background. The prevalence of HV was quite different across 
the three cohorts, suggesting a potential phenotypic heterogeneity due to assessment of HV, 
non-genetic host effects (such as age, sex and BMI distribution) and/or environmental 
exposures. The assessment of HV in FHS was slightly different, but not substantially 
different, than that used in JoCo OA and GOGO. This potential phenotypic misclassification 
may also reduce the statistical power to identify SNP-phenotype associations. Due to lack of 
information, we cannot evaluate whether environmental exposure (such as shoe-wear or 
physical activities) to risk factors associated with HV were different across the three studies, 
and we did not have adequate statistical power to test all potential gene-by-environment 
interactions.
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A further caveat is that HV was considered as a dichotomous variable with a cut-off of 15 
degrees, with no data available on severity. Statistical power may be further improved by 
performing association analysis with ordinal[51, 52] or continuous[53] measurement of HV. 
However, in the current study, not all of the participating studies had such measurements.
In summary, this is the first GWAS meta-analysis to examine SNPs associated with HV. 
Although we did not identify genome-wide significant SNPs using the stringent p-value 
cutoff, our identified sex-specific genome-wide suggestive loci and genome-wide significant 
sex-by-SNP interactions implied that the potential pathophysiological mechanisms of HV 
may be related to skeletal development and inflammation as well as biological pathways 
previously observed for other OA phenotypes, suggesting the complexity of the etiology 
underlying HV. In addition, similar to findings in GWAS of OA phenotypes, the variation in 
results from sex-specific analysis suggested that the genetic mechanisms behind the 
development of HV might be quite different between men and women as well as the 
potential environment-by-sex interactions. Our study provides several important and 
promising findings that need further replication in additional independent samples of 
Caucasians and other race/ethnicities, as well as validation for their potential functional 
involvement in the pathophysiological and biological mechanisms of HV.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Principal characteristics of participants by study cohort
Framingham (N=2,263) JoCo Caucasian (N=915) JoCo African Americans (N=327) GoGo Caucasian (N=1,231)
Hallux Valgus Hallux Valgus Hallux Valgus Hallux Valgus
Yes No Yes No Yes No Yes No
N 709 (31.3%) 1554 565 (61.7%) 350 225 (68.8%) 102 512 (41.6%) 719
Female 516 (40.7%) 751 368 (65.1%) 197 152 (69.1%) 68 437 (43.9%) 558
Men 193 (19.4%) 803 197 (56.3%) 153 73 (68.2%) 34 75 (31.8%) 161
Age (yrs) 70.1 (11.54) 66.6 (10.55) 63.2 (9.21) 60.5 (8.34) 61.2 (9.31) 58.8 (8.80) 60.5 (8.34) 67.3 (8.52)
BMI (kg/m2) 27.5 (4.96) 28.8 (5.53) 29.9 (5.96) 29.8 (5.58) 32.3 (7.83) 33.5 (7.77) 29.8 (5.58) 28.2 (5.19)
Weight (lbs) 162.4 (36.86) 178.9 (39.94) 179.3 (44.06) 185.8 (44.13) 192.1 (50.76) 201.3 (51.01) 164.7 (35.79) 167.8 (38.08)
Number of participants in each study cohort was for persons with both HV phenotype and GWAS genotypes.
Age is age at time of foot examination.
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Table 2
Sex-specific GWAS meta-analyses in Caucasians (2,827 women and 1,582 men)
SNP CHR Genes Alleles MAF Beta SE P-values Results from opposite sex SNP-by-Sex
Beta SE P-values Interaction-P
Top Associated SNPs in Men (p < 5×106)
rs9854162 3 NLGN1* C -> T 0.18 0.63 0.135 2.51E-06 0.05 0.081 5.10E-01 2.20E-04
rs4476613 4 FAT4 G -> C 0.24 0.48 0.105 4.63E-06 0.13 0.072 6.42E-02 6.38E-03
rs10224956 7 BBS9* G -> A 0.16 0.53 0.118 4.96E-06 −0.08 0.077 2.84E-01 1.29E-05
rs9675316 17 AXIN2 T -> G 0.01 1.14 0.227 5.46E-07 −0.50 0.342 1.45E-01 6.80E-05
Top Associated SNPs in Women (p < 5×10−6)
rs2242411 5 MRPL36 C -> T 0.46 −0.29 0.061 2.24E-06 −0.15 0.095 1.26E-01 2.07E-01
rs12214759 6 C6orf70 G -> A 0.33 0.33 0.071 2.40E-06 −0.19 0.114 9.99E-02 1.01E-04
rs4744678 9 ANXA1 G -> A 0.49 −0.29 0.062 4.35E-06 −0.11 0.094 2.42E-01 1.19E-01
rs7996797 13 ESD G -> A 0.39 0.31 0.062 7.21E-07 −0.03 0.095 7.87E-01 3.34E-03
rs17783396 14 C14orf179 G -> A 0.05 −1.05 0.220 2.10E-06 0.52 0.331 1.13E-01 7.97E-05
rs9889124 16 FAM92B C -> T 0.13 −0.46 0.097 1.72E-06 −0.27 0.153 8.05E-02 2.79E-01
In each locus, only the most significantly associated SNP is listed.
*SNPs are located inside genes
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Table 3
Sex-by-SNP Interaction GWAS Meta-analysis in Caucasians (2,827 women and 1,582 men)
SNP Chr Gene Alleles SNP-by-Sex Men Women
Interaction-P MAF Beta P-values MAF Beta P-values
rs6953348 7 BBS9* G -> A 1.05E-06 0.22 0.52 1.23E-05 0.18 −0.10 1.74E-01
rs10283141 8 RUNX1T1; SLC26A7 G -> A 5.86E-07 0.04 0.86 4.43E-05 0.04 −0.49 3.89E-03
rs1519847 8 MLZE C -> T 4.34E-06 0.37 0.29 2.67E-03 0.39 −0.23 1.32E-04
rs1563374 11 MRGPRX3 C -> A 4.07E-09 0.02 1.73 2.61E-05 0.02 −1.24 2.30E-05
rs4550343 13 SLITRK6 G -> A 8.86E-06 0.29 0.39 1.16E-04 0.32 −0.15 2.62E-02
rs6135498 20 MACROD2* T -> C 2.04E-06 0.41 −0.31 1.65E-03 0.40 0.25 1.17E-04
In each locus, only the most significantly associated SNP is listed.
Bold: SNPs with genome-wide significance (interaction p-values <5E-08)
*SNPs are located inside genes
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